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Abstract
Prokaryotic ubiquitin-like protein (Pup) in Mycobacterium tuberculosis (Mtb) is the first known post-translational small
protein modifier in prokaryotes, and targets several proteins for degradation by a bacterial proteasome in a manner akin to
ubiquitin (Ub) mediated proteolysis in eukaryotes. To determine the extent of pupylation in Mtb, we used tandem affinity
purification to identify its ‘‘pupylome’’. Mass spectrometry identified 55 out of 604 purified proteins with confirmed
pupylation sites. Forty-four proteins, including those with and without identified pupylation sites, were tested as substrates
of proteolysis in Mtb. Under steady state conditions, the majority of the test proteins did not accumulate in degradation
mutants, suggesting not all targets of pupylation are necessarily substrates of the proteasome under steady state
conditions. Four proteins implicated in Mtb pathogenesis, Icl (isocitrate lyase), Ino1 (inositol-1-phosphate synthase), MtrA
(Mtb response regulator A) and PhoP (phosphate response regulator P), showed altered levels in degradation defective Mtb.
Icl, Ino1 and MtrA accumulated in Mtb degradation mutants, suggesting these proteins are targeted to the proteasome.
Unexpectedly, PhoP was present in wild type Mtb but undetectable in the degradation mutants. Taken together, these data
demonstrate that pupylation regulates numerous proteins in Mtb and may not always lead to degradation.
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Introduction
Most individuals who are infected with Mtb do not develop
tuberculosis. However, despite effective control of Mtb growth in
healthy individuals, Mtb is rarely sterilized from the body [1].
Although numerous aspects of the immune system are responsible
for slowing the growth of Mtb, the antimicrobial molecule nitric
oxide (NO) appears to be essential for this process (reviewed in
[2]). In a previous effort to identify new targets for tuberculosis
therapy, Mtb mutants were screened for hyper-susceptibility to NO
[3]. This screen identified two previously uncharacterized
proteins, Mycobacterium proteasomal ATPase (Mpa) and protea-
some accessory factor A (PafA). Proteasome protease activity
encoded by prcBA appears to be essential for optimal in vitro
growth of Mtb [4,5,6] but not the non-pathogenic relative M.
smegmatis [7,8].
Follow up studies revealed that PafA attaches a small protein,
Pup, to at least three substrates to target them for degradation by
the Mtb proteasome [9,10]. Pup binds to Mpa at a ratio of 1:6
[9,11,12,13], which is thought to lead to protein unfolding for
delivery into the proteasome core protease, although the latter has
not been definitively demonstrated. Importantly, pupylation and
proteasome function are essential for the virulence of Mtb for
reasons that remain a mystery[3,4,14].
Pupylation is currently the only known post-translational protein-
to-protein modification system in prokaryotes. Pup attaches to
substrate lysines (K, Lys) via isopeptide bonds in a manner
reminiscent of ubiquitin (Ub) and ubiquitin-like modifier (Ubl)
conjugation to proteins in eukaryotes (reviewed in [15]). Proteins
targeted for proteasomal degradation in eukaryotes are usually
tagged with polyubiquitin chains [16,17,18]. Regulatory complexes
associated with proteasomes recognize polyubiquitin chains, and
remove and recycle Ub monomers for additional ubiquitylation
reactions [19]. We do not know if Pup forms chains, or if it is
recycled like Ub. Importantly, the only common feature between
Ub and Pup appears to be a di-glycine motif (GG, Gly-Gly) at or
near their C-termini. Ub attaches to substrate Lys via a C-terminal
Gly carboxylate. Unlike Ub, Pup attaches to substrate Lys by a
carboxylate group at a C-terminal glutamine (Q, Gln); however this
Gln is deamidated prior to ligation [9] by deamidase of Pup (Dop)
[10].ThustheformerGlnbecomesaglutamate(Glu,E)anditisnot
known which carboxylate, the alpha or gamma, forms the
isopeptide bond with substrate Lys (‘‘GGE,K’’). Although the
details of pupylation are unclear, PafA is sufficient to ligate
deamidated Pup to substrates in vitro [10].
In a previous study, two-dimensional (2D) SDS-PAGE analysis
showed that the proteomes of wild type and proteasome-defective
Mtb nearly overlapped; only two proteins, FabD (malonyl CoA-
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oxobutanoate hydroxymethyltransferase), were conspicuously
dependent on Mtb proteasome activity for turnover under routine
culture conditions or in the presence of acidified nitrite, a source of
NO [20]. Both proteins were found to be pupylated [9]. In
addition, we previously determined that Mpa, the presumed
proteasomal ATPase, is also a degradation substrate of the
proteasome [20] and is pupylated [9]. At the time, these results led
us to hypothesize that either the Mtb proteasome had few
substrates, or that other proteins were not as robustly turned over
as FabD and PanB under these conditions.
With the discovery of Pup, we were better able to comprehen-
sively identify putative proteasomal substrates by purifying
proteins that were covalently attached to Pup in Mtb. Here, our
goals were to determine (1) if there were targets of pupylation in
addition to FabD, PanB and Mpa; (2) if Pup formed chains like
Ub; and (3) if pupylated proteins were necessarily proteasome
targets. Based on results presented here and elsewhere [9,20], we
have now found a total of 58 pupylation targets, revealing a much
broader role for Pup in protein regulation than previously
expected [20]. In addition, no Pup chains were identified,
suggesting poly-pupylation is not required for proteolysis or other
physiological processes. Interestingly, several pupylation targets
did not show increased steady state levels in degradation-defective
mutants under the conditions tested. Finally, our study revealed
clues that may suggest a link between proteasome-dependent
proteolysis and Mtb pathogenesis.
Results
Mass Spectrometry Identifies Numerous Pupylated
Proteins in Mtb
We used a tandem affinity purification (TAP) approach to isolate
proteins covalently associated with Pup in Mtb under routine
culture conditions (see Materials and Methods). This technique has
successfully identified Ub and Ub-related modifier conjugated
substrates in eukaryotes (reviewed in [21,22,23]). Using tandem
mass spectrometry (MS/MS) we identified 604 proteins including
Pup (Table S1), representing ,15% of the total predicted proteome
of Mtb strain H37Rv [24,25]. Due to the high sensitivity of MS/MS
it is likely that numerous proteins are not genuine pupylation
targets but co-purified with true pupylated substrates. We also
predict that the pupylome changes depending on the culture
conditions, thus we will refer to the proteins identified under
routine culture conditions as the ‘‘RCC pupylome’’.
The Pup site of attachment was identified for 55 proteins,
including the previously characterized FabD (Tables 1, S2) [9].
Two proteins had also been identified as pupylation targets in the
non-pathogenic saprophyte M. smegmatis (Ino1, SodA); the same
Lys in Ino1 was modified in both mycobacterial species [7]
(Table 1). All linkages were GGE,K as described for previously
identified pupylation targets. There was no evidence of Pup,Pup
conjugates suggesting Pup does not form chains, however, it is
possible that Pup,Pup conjugates are present beyond the level
detection, or form only under certain conditions.
Of the 55 proteins with identifiable pupylation sites, most
appeared to only have one site of Lys modification. Three
exceptions included FabG4 (probable 3-ketoacyl-acyl carrier
protein reductase) and Bcp (probable bacterioferritin co-migratory
protein), each with two pupylation sites; and HspX (alpha
crystallin homologue), which could have any of four of eight Lys
pupylated (Table 1, S2). HspX was particularly striking as it is
among the smallest proteins (16.3 kD) identified in our analysis. It
was not clear if a single polypeptide could have different Lys
occupied by Pup at the same time because peptides with possible
pupylation sites were also found in unmodified form (Table S1).
The location of the modified Lys did not appear to favor a
particular region (e.g. N- or C-termini) of the target proteins, and a
conspicuous motif near the modified Lys was not identified. It is
perhaps not surprising that a robust motif that indicates a favored
Lys for pupylation was not found. With the exception of the
eukaryotic small ubiquitin-like modifier (SUMO) family of
proteins (reviewed in [26]), conserved motifs surrounding modified
residues have not been observed for Ub or other Ubls.
Pupylation Targets Include Proteins from Eight
Functional Classifications
Genes in Mtb are assigned to one of 11 functional classifications,
including stable RNAs, insertion sequences and phages [24]. All
proteins identified in the RCC pupylome fall into one of seven
classifications (Table 2). Notably absent were ‘‘proteins of
unknown function’’ and ‘‘PE (proline-glutamate) and PPE
(proline-proline-glutamate) proteins’’; PE/PPE genes are numer-
ous in Mtb, are predicted to encode secreted proteins, but their role
in Mtb biology is poorly understood [27]. It is possible that the
predicted extra-cytoplasmic membrane localization of PE/PPE
Table 1. Proteins with known pupylation sites.
ORF: Protein, MW:
Modified
Lys: ORF:
Protein,
MW:
Modified
Lys:
Rv0046c Ino1 (40.1) 73 Rv2074c 91.3 47
Rv0073 35.8 65 Rv2115c Mpa (67.4) 591
Rv0148 29.8 280 Rv2222c GlnA2 (49.6) 363
Rv0242c FabG4 (46.8) 168, 381 Rv2241 AceE (100.1) 346
Rv0357c PurA (46.8) 292 Rv2243 FabD (30.8) 173
Rv0440 GroEL2 (56.7) 132 Rv2280 48.1 354
Rv0467 Icl (47.0) 334 Rv2419c 24.2 47
Rv0525 22.2 136 Rv2449c 44.3 127
Rv0640 RpkL (15.0) 101 Rv2477c 61.9 338
Rv0684 FusA (77.1) 307 Rv2501c AccA1 (70.6) 321
Rv0733 Adk (20.1) 94 Rv2521 Bcp (17.0) 12, 150
Rv0814c SseC2 (10.2) 98 Rv2606c SnzP (31.3) 271
Rv0859 FadA (42.4) 189 Rv2624c 29.4 82
Rv0896 GltA2 (47.9) 328 Rv2676c 26.2 44
Rv1013 Pks16 (58.4) 528 Rv2737c RecA (85.4) 762
Rv1017c PrsA (35.5) 29 Rv2752c 59.5 502
Rv1018c GlmU (51.6) 362 Rv2845c ProS (63.3) 173
Rv1077 CysM2 (48.6) 428 Rv2859c 32.4 289
Rv1094 DesA2 (31.4) 145 Rv2987c LeuD (21.8) 154
Rv1185c FadD21 (62.8) 355 Rv3002c IlvN (18.2) 44
Rv1295 ThrC (37.3) 151 Rv3045 AdhC (37.1) 209
Rv1308 AtpA (59.3) 489 Rv3149 NuoE (27.2) 45
Rv1315 MurA (44.0) 81 Rv3246c MtrA (25.3) 207
Rv1392 MetK (43.0) 345 Rv3248c SahH (54.3) 474
Rv1655 ArgD (40.9) 314 Rv3418c GroES (10.7) 100
Rv1996 33.9 88 Rv3720 46.9 277
Rv2029c PfkB (35.4) 283 Rv3846 SodA (23.0) 202
Rv2031c HspX (16.2) 64, 85,
114, 132
doi:10.1371/journal.pone.0008589.t001
M. tuberculosis Pupylome
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in the RCC pupylome, which did not include culture supernatants
or completely solubilized membranes.
Members of three classifications appeared to be over-represent-
ed in the RCC pupylome when compared to their representation
in the entire genome. These included ‘‘intermediary metabolism’’,
‘‘lipid metabolism’’, and ‘‘detoxification/virulence’’ (Table 2).
Detoxification/virulence proteins included the chaperonins
GroES, GroEL1 and GroEL2; pupylation sites were identified
for GroES and GroEL2 (Tables 1, S2). We previously reported
that the proteasomal ATPase Mpa is itself a target of pupylation
and proteasomal degradation [9,20], and have now identified the
pupylation site (Tables 1, S2). Interestingly, several other proteins
associated with proteasome function (PafA and Dop) were also
identified (Table S1) [3,10,28]. However, we have not been able to
confirm that these proteins are covalently modified with Pup.
‘‘Cell wall processes and membrane proteins’’ were under-
represented compared to the predicted proteome devoted to this
classification. This is likely due to experimental bias and we
presume much of the membrane and its components were lost
during processing. Of the proteins in this class with confirmed
pupylation sites, none was a predicted secreted or integral
membrane protein.
Identification of Four New Candidate Proteasome
Substrates
To determine if proteins identified by TAP/MS were likely
proteasome degradation substrates, we cloned 41 genes listed in
Table S1, including 18 of the 27 genes encoding transcriptional
regulators. None of these genes was induced (or repressed) in mpa
or pafA mutant Mtb as determined by microarray analysis (R.A.F.,
K.H.D, manuscript in preparation). Each was cloned downstream
of a heterologous promoter and ribosome-binding site (RBS) with
a His6 epitope encoded at the C-terminus (see Methods; Table S3).
Plasmids were used to transform wild type, pafA and mpa null
mutant strains of Mtb, and steady state levels of putative substrates
were examined by detection of the His6-epitope by immunoblot-
ting. Of the 41 constructs, eight plasmids (pSYMP-Rv0681,
-phoY2,- hspX,- ino1,- leuD,- fadE24,- tsf, and -cmaA2) resulted in
undetectable recombinant protein or very few transformants of all
three Mtb test strains, although TAP/MS had previously shown
that three of the test proteins (HspX, Ino1, Tsf) were pupylated in
the RCC pupylome (Table 1). The inability to detect recombinant
protein may suggest the test proteins are unstable or toxic when
overproduced.
Recombinant Icl (isocitrate lyase) and MtrA (Mtb response
regulator A) accumulated in the mpa and pafA mutants, suggesting
they are targets for proteasomal degradation (Fig. 1A). Both
proteins had identifiable pupylation sites (Table 1). Icl is involved
in the glyoxylate shunt pathway, which allows Mtb to utilize fatty
acids or acetate as a carbon source [29] and is required for
persistent infection of mice [30,31]. MtrA is a response regulator
that appears to be essential for Mtb growth in vitro as attempts to
delete mtrA have been unsuccessful [32]. Over-expression of mtrA
in Mtb results in slowed growth in cultured macrophages and mice,
but not in broth culture [33]. The physiological relevance of
artificial over-production of this transcriptional regulator remains
to be determined. Although we found recombinant MtrA-His6 is
more stable in proteasome-defective mutants, we do not know if
endogenous MtrA accumulates in mpa or pafA mutants, or if
pupylation affects MtrA activity.
We were interested in determining if Ino1 was a proteasome
substrate since it was identified in both M. smegmatis [7] and Mtb
(Table 1) as a pupylated protein. Ino1 catalyzes the first committed
step of inositol synthesis and is essential for the growth and
virulence of Mtb [34]. Because recombinant, over-produced Ino1-
His6 was undetectable in Mtb we raised polyclonal antibodies to
Mtb Ino1 to examine endogenous Ino1 levels. Like MtrA and Icl,
Ino1 accumulated in the pafA and mpa mutant Mtb strains, and
thus appears to be a proteasome substrate (Fig. 1B). The pupylated
species, Pup,Ino1, appears to accumulate in the mpa mutant
(Fig. 1B, asterisk) similarly to Pup,FabD [9].
In contrast to MtrA, the two-component response regulator
PhoP was surprisingly less stable in the pafA and mpa mutants. In
fact, PhoP-His6 was undetectable in the mutant strains (Fig. 1C).
We speculate that PhoP interacts with another protein that is a
pupylated proteasome substrate; this protein may function to
target PhoP to another protease. Thus the accumulation of this
hypothetical protein in a pafA or mpa mutant would reduce PhoP
levels in these strains.
In addition to proteins identified by TAP/MS, we re-examined
2D-SDS-PAGE gels from a previous study [20] and identified a
faint protein spot that was in lysates from an mpa mutant (Fig. 1D),
but not wild type Mtb. This protein, PhoH2, was found in the
RCC pupylome, is similar to PhoH from other organisms, and is
predicted to bind ATP (http://genolist.pasteur.fr/TubercuList/).
Although PhoH2 is annotated as a ‘‘phosphate starvation induced
protein’’, its actual function is unknown. Early attempts to
ectopically express phoH2 in mycobacteria resulted in toxicity to
mpa and pafA mutants under normal growth conditions therefore
we raised polyclonal antibodies to PhoH2-His6 to examine
endogenous protein. PhoH2 accumulated robustly in the pafA
and mpa mutants (Fig. 1E, left) in a manner similar to FabD, PanB
[20], and Ino1 (Fig. 1B). We eventually succeeded in ectopic
expression of phoH2-His6 using the plasmid described for the other
test substrates, and observed similar results with the recombinant
protein (Fig. 1E, right).
Several Proteins Do Not Show Changes in Steady State
Levels in Degradation Mutants under Standard Growth
Conditions
Most of the recombinant proteins tested, including five shown to
be pupylation substrates by TAP/MS (Table 1), demonstrated
little to no change in steady state levels under the conditions tested
(Fig. 2A, S1). Interestingly, over-exposure of immunoblots
revealed what appears to be a pupylated form of Rv2859c, a
Table 2. Classification of proteins identified in the Mtb
pupylome.
Classification:
No. with
pupylated
peptide:
Percent of
pupylome
1:
Percent of
predicted
proteome
2:
Intermediary metabolism 25 45 22
Conserved hypotheticals 7 13 26
Lipid metabolism 8 15 6
Information pathways 4 7 6
Cell wall, membrane- 4 7 18
associated
Detoxification/virulence 6 11 3
Regulators 1 2 5
1Percentage of proteins of this class identified over the total number of
pupylated proteins identified by MS.
2Percentage of this class of proteins in the total predicted Mtb proteome.
doi:10.1371/journal.pone.0008589.t002
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The abundance of both the pupylated and unmodified form of
Rv2859caresimilarbetweenwildtypeandmpamutantMtb(Fig.2A,
last panel), suggesting the pupylated form of this protein is not
necessarily targeted for degradation under these conditions.
Although the His6 epitope did not previously hinder the
degradation of several test substrates [20] (Fig. 1), we cannot rule
out that the His6 tag negatively affects the stability of certain
proteins in Mtb. Additionally, over-production of certain substrates
may overwhelm the proteasome system, masking any differences
in protein stability. Because we were unable to detect differences in
the steady state stability of Adk (probable adenylate kinase),
FabG4 (3-ketoacyl-acyl carrier protein reductase), Mkl (possible
ribonucleotide-transport ATP-binding protein), or DesA1 (stear-
oyl-ACP destaturase) in total cell lysates, we purified the epitope-
tagged proteins using affinity chromatography from wild type and
mpa mutant Mtb to determine what proportion of these proteins
was pupylated. Although we were able to purify the recombinant
proteins from Mtb (Fig. 2B), we were unable to detect pupylated
species of these proteins (not shown) despite MS data showing they
are indeed targets of pupylation (Table 1). This suggests that these
proteins are pupylated at extremely low levels or that the epitope
tag on each prohibits efficient pupylation.
We also used available antibodies to examine the endogenous
levels of two proteins identified in the pupylome, ClpP (caseinolytic
protease) and PknG (protein kinase G). Neither protein was found
to have a confirmed pupylated site therefore it was not clear if
these were actual targets of pupylation. However, we chose to
examine the endogenous levels of these proteins because both are
predicted to be essential either for Mtb viability or pathogenesis
[6,35]. Mtb encodes two ClpP orthologues, ClpP1 and ClpP2,
which appear to be encoded in an operon. TAP/MS identified
both ClpP1 and ClpP2 (Table S1). ClpP proteases are similar to
proteasomes in that they form chambers and require ATP for
regulated proteolysis (reviewed in [36]). Unlike proteasomes,
which are only found in bacteria of the class Actinomycetes, ClpP
proteases are found in all bacteria sequenced to date. Polyclonal
antibodies to ClpP1/2 detected a single band in Mtb lysates
(Fig. 2C, left). ClpP1 and ClpP2 are similar in molecular weight
(22 and 24 kD, respectively) therefore we could not determine
which of the two proteins, if not both, was detected. Nonetheless,
we did not observe a difference in the steady state levels of this
protein among the wild type and mutant Mtb strains. We also
examined the steady state levels of PknG in wild type and
proteasome defective Mtb strains. PknG is a serine-threonine
kinase that is required for Mtb survival in cultured macrophages
[35]. Similar to ClpP1/2, we did not detect a difference in steady
state PknG levels among the Mtb strains (Fig. 2C, right).
Enzymes of the Fatty Acid Synthase II (FASII) Pathway Are
Differentially Regulated by the Pup-Proteasome System
Every protein encoded in the fatty acid synthase II (FASII)
elongation cycle operon (FabD, AcpM, KasA, KasB, AccD6) was
identified in the pupylome (Table S1), suggesting that nearly all
proteins in this pathway are targets of pupylation, or that
unpupylated FASII enzymes co-purified with pupylated proteins.
Figure 1. Identification of four proteasome substrate candidates. (A) Immunoblots using antibodies to His5 show that recombinant Icl-His6
and MtrA-His6 accumulate in proteasome-defective Mtb strains. (B) Polyclonal rabbit antibodies raised against Ino1-His6 detect accumulated
endogenous Ino1 in pafA and mpa mutants compared to wild type Mtb H37Rv. PhoP-His6 is undetectable in mpa and pafA mutants. (C) PhoP-His6 is
undetectable in mpa and pafA mutants. (D) Region of 2D SDS-PAGE gels that shows a unique spot in mpa mutant soluble cell lysates that was
identified by MALDI-TOF MS as PhoH2. (E) Polyclonal rabbit antibodies raised against PhoH2-His6 detect endogenous PhoH2 in pafA and mpa
mutants but not wild type Mtb H37Rv (left). Antibodies to His5 detect PhoH2-His6 synthesized in the pafA and mpa mutants but not wild type Mtb
transformed with pSYMP-phoH2-His6 (right). Lower panel is a longer exposure of the same blot. Dihydrolipoamide acyltransferase (DlaT) is the loading
control for all panels. All data are representative of at least two independent experiments from biological replicates.
doi:10.1371/journal.pone.0008589.g001
M. tuberculosis Pupylome
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but genetically unlinked, was shown to be pupylated on either of
two Lys (Table 1), but not a proteasome substrate under normal
culture conditions (Fig. 2A). FabD is encoded by the first gene in
the FASII operon and is a robust degradation substrate [9,20].
Unlike FabD, KasA and KasB (beta-ketoacyl-ACP synthases 1 and
2, respectively) steady state levels were not noticeably different
between the wild type and mpa and pafA strains (Fig. 3A, S1). We
purified KasA-His6 and KasB-His6 from M. smegmatis for anti-Pup
immunoblot analysis and observed a specific Pup-reactive protein
in the KasB pull down (Fig. 3B), but not in the KasA sample (not
shown). We then determined if Pup,KasB was present in Mtb.A s
a positive control for the pull down of pupylated substrate, we
purified Rv2859c-His6, which has a known pupylation site and for
which a pupylated species could be detected in total cell lysates
(Fig. 2A). As expected, we detected Pup,Rv2859c in the wild type
and mpa Mtb strains, but not in the pafA (pupylation-deficient)
mutant (Fig. 3C). To our surprise, although Pup,KasB was
present in wild type Mtb, it was not detected in either the pafA or
the mpa mutant (Fig. 3C). This suggested that a defect in Mpa
function and/or proteolysis by the proteasome results in either
abrogated pupylation, or possibly increased ‘‘de-pupylation’’ of
KasB. Taken together, it appears that the Pup-proteasome
pathway differentially affects enzymes of the FASII pathway.
Discussion
In this study we identified the pupylation sites of 55 proteins in
Mtb, including the previously identified FabD and Mpa [9]. Using
the same pull-down techniques for identifying Pup,FabD and
Pup,PanB [9], we determined that KasB is also pupylated (Fig. 3).
We presume the degradation substrate PhoH2 is also pupylated,
Figure 2. Steady state levels of several RCC pupylome proteins
in wild type, pafA and mpa mutants. (A) Five pupylation substrates
do not show increased steady state levels in proteasome-defective Mtb.
Adk, FabG4, Mkl, DesA1 and Rv2859c were all epitope tagged with His6
at the C-termini. FabG4-His6 is predicted to have a MW of 48 kD,
corresponding with the top band; a lower MW species appears in all
strains tested, perhaps indicating proteolytic processing or an
alternative translation initiation site after the predicted start codon.
DlaT loading control is shown below each anti-His5 immunoblot (IB). (B)
Purification of His6-tagged Adk, DesA1, Mkl, and FabG4 from wild type
and mpa Mtb strains did not identify pupylated proteins. The upper
band is the presumed full length FabG4 (without Pup). (C) IB analysis
shows that endogenous ClpP1/2 and PknG do not accumulate in
proteasome defective Mtb under routine culture conditions. Equivalent
cell numbers from cultures grown to an optical density (ODA580)=1.5
were analyzed. DlaT is the loading control for all samples.
doi:10.1371/journal.pone.0008589.g002
Figure 3. Fatty acid synthase (FASII) enzymes are differentially
regulated by the Pup-proteasome system. (A) Anti-His5 immuno-
blot of FASII pathway enzymes that are confirmed or putative
pupylation targets have differing steady state levels in proteasome-
defective Mtb. The same KasA and KasB samples are also shown with
the loading controls in Fig. S1. KasA (MW=43 kD) migrates more slowly
than KasB (MW 46 kD); similar observations were previously reported
[54]. The membrane was stripped and endogenous FabD was examined
with FabD antibodies. (B) KasB-His6 is positive for pupylation. Pup
antibodies show a specific Pup-reactive protein (*) from KasB-His6
purified from M. smegmatis. The protein above the indicated band (*) is
non-specific and recognized in all samples from M. smegmatis. All data
are representative of at least two independent experiments from
biological replicates. (C) Pup,KasB (*) is undetectable in the pafA and
mpa mutants. His6-tagged Rv2859c and KasB were purified from Mtb
and analyzed by immunoblotting with antibodies to Pup, stripped, and
then re-examined with antibodies to His5. Due to the unexpected result
for the mpa mutant, we confirmed that the mpa strain was pupylation
proficient by anti-Pup immunoblotting (not shown). The higher MW
species appears to specifically co-purify with Pup,KasB and is
recognized by the Pup antibody. Equivalent cell numbers were
analyzed and all experiments are representative of two replicates.
doi:10.1371/journal.pone.0008589.g003
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have more than one pupylation site, but we did not identify Pup
chains. To date, we have identified seven likely proteasome
substrates, including FabD, PanB, Mpa [20]; and the newly
identified PhoH2, Icl, MtrA, and Ino1.
Five of proteins with confirmed pupylation sites were not
differentially turned over between wild type and proteasome-
defective Mtb (Fig. 2). It is notable that three of the six known
degradation substrates, FabD, PanB and PhoH2, were identified
by comparing the steady state proteomes of wild type and
degradation defective Mtb by 2D-SDS-PAGE; the two proteomes
appeared nearly identical [20]. These data are also consistent with
the observation that numerous anti-Pup reactive proteins are
present in Mtb, and the abundance of most of these proteins does
not change in a degradation mutant [9]. However, the lack of
accumulation of pupylated substrates in a degradation-defective
strain might be due to negative feedback regulation, where a defect
in proteolysis results in reduced pupylation.
There are several possible explanations for why recombinant
pupylation targets are not proteasome substrates. First, the reasons
may be technical; it is possible that over-production of certain
proteins overwhelms the Pup-proteasome system, masking any
observable differences in proteolysis of these substrates. It is also
possible that the His6-epitope prevents pupylation or degradation
of certain proteins. Additionally, not all proteins may be pupylated
to the same degree; for all of the test substrates, we do not know
what percentage of each protein is pupylated. We also predict that
certain proteins are differentially pupylated (and degraded) under
specific conditions. Other proteins may be required to deliver a
pupylated substrate to the proteasome, and these co-factors may
not be expressed under the conditions tested. Finally, not all
pupylated proteins may be targets of proteasomal degradation, a
potentially exciting observation. Ub and related modifiers have
numerous activities in eukaryotes [37], controlling processes from
signal transduction to regulating enzyme activity, in addition to
targeting proteins for degradation, therefore, we speculate that
Pup has widespread, degradation-independent importance in
bacterial physiology. How and why certain proteins are more
efficiently targeted for pupylation and/or proteolysis are questions
currently under investigation.
It is striking that the steady state level of one protein, FabD, is
strongly regulated by pupylation while other confirmed (KasB,
FabG4) and presumed (KasA) pupylated proteins in the same
pathway are not rapidly turned over under the same conditions.
Perhaps most intriguing is the observation that not only does
Pup,KasB not accumulate in an mpa mutant, but Pup,KasB
appears to be present at extremely low to undetectable levels in this
strain (Fig. 3C). We do not yet understand the significance of this
result, but we speculate that the absence of Mpa either reduces the
pupylation of KasB, or increases the removal of Pup. It is also possible
that Mpa protects Pup,KasB from proteolysis by another protease.
Because proteasome function is essential for Mtb pathogenesis
[3,4,14,20,38] we predicted the identification of proteasomal
degradation substrates may give clues to link proteasome-
dependent proteolysis and virulence. The inability to turn over
potentially hundreds (or even a handful) of proteins could greatly
compromise bacterial survival when adapting to a new environ-
ment, such as the inside of an activated macrophage. It is
unknown what effect, if any, the accumulation of metabolic
enzymes, such as FabD, PanB, Ino1, Icl or PhoH2, has during an
infection. Our data show that several virulence-associated proteins
are regulated by proteasomal degradation. The transcriptional
response regulator MtrA is pupylated and appears to be a
proteasome substrate. Over-expression of MtrA attenuates Mtb in
macrophages and mice [33] thus the accumulation of MtrA in a
proteasome mutant could potentially contribute to the weakened
virulence of proteasome-defective Mtb. In contrast to MtrA, the
global regulator PhoP was less stable in the pafA and mpa mutants.
PhoP is essential for the virulence of numerous pathogens,
including Mtb [39,40,41,42,43]. PhoP is required for Mtb growth
in both macrophages and mice [39,42]. A point mutation in the
DNA binding domain of PhoP in the avirulent Mtb strain H37Ra
is thought to account for part of its attenuation compared to the
virulent parent strain H37Rv [44,45]. The cause of attenuation of
a phoP Mtb mutant is unclear, although PhoP appears to impact
numerous aspects of Mtb biology, including lipid metabolism
[39,41,46], early and enduring hypoxic responses [46], respiration,
and virulence gene expression [46,47]. The lack of PhoP in the
pafA and mpa mutants thus suggests an important role for
proteasome activity on Mtb pathogenesis. A long-term goal will
be to determine why PhoP stability is decreased in proteasome-
defective Mtb.
Although our study has shed light on several aspects of the Pup-
proteasome system, numerous additional questions have been
raised. For example, how does a single ligase, PafA, target at least
58 or potentially hundreds of proteins for pupylation in Mtb?I n
eukaryotes, Ub ligases are numerous in order to provide specificity
to ubiquitylation; how is specificity imparted in the Pup system?
What signals in addition to Pup are required to target proteins for
proteolysis? Does Pup play non-degradative roles in the cell?
There is little doubt that considerable effort will be needed to
determine how so many processes targeted by pupylation impact
the physiology of Mtb.
Materials and Methods
Bacterial Strains, Plasmids, Media
All strains, primers and plasmids are listed in Table S3. For
cloning and transformations we used E. coli DH5a (Gibco, BRL).
For protein synthesis we used E. coli ER2566 [48]. All Mtb work
was performed in a Biosafety Level 3 (BSL3) suite. Mtb H37Rv was
used for all Mtb studies. mpa and pafA mutants are described
elsewhere [3]. E. coli strains were grown in Luria Bertani (LB)
Broth (Difco). Mtb strains were grown on 7H11 Middlebrook agar
supplemented with oleic acid, dextrose and catalase (Middlebrook
OADC, Difco) or in Middlebrook 7H9 broth (Difco) supplement-
ed with 0.2% glycerol, 0.05% Tween-80, 0.5% bovine serum
albumin, 0.2% dextrose and 0.085% sodium chloride. Mtb
cultures were grown without shaking in 75 cm
2 vented flasks in
humidified incubators with or without 5% CO2. For Mtb,
kanamycin and hygromycin were used as needed at 50 mg/ml
each. For E. coli, kanamycin and hygromycin were used at 100 and
150 mg/ml, respectively. Isopropyl-b-D-thiogalactopyranoside
(IPTG) was used at a final concentration of 1 mM.
For the identification of pupylated targets in Mtb, a tandem
affinity tagged version of Pup (pMN-His6-Strep-Pup), was
constructed. Mtb phoH2, ino1, and fabD were cloned into
pET24b(+) for the purification of His6-FabD, Ino1-His6, and
PhoH2-His6 for antibody production (see Table S3 for primers
used for cloning).
Forover-productionofputativepupylation targetsinMtbweused
a modified form of pMN402, which has green fluorescent protein
(gfp) encoded downstream of a mycobacterial heat shock protein
promoter (hsp60p) and a consensus bacterial RBS [49]. Transfor-
mation of pMN402-derivatives that had gfp replaced with genes of
interest often resulted in toxicity to Mtb, most likely due to strong
over-expression of the cloned gene from the hsp60p and robust
translation from the consensus RBS. To reduce protein synthesis by
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and a start codon was cloned downstream of the gfp RBS and start
codon. Genes of interest were cloned starting with the second start
codon. We predicted the final plasmid expressed a transcript
encoding a short peptide followed by the test substrate (all final
constructs were designated ‘‘pSYMP’’). As a result few of the test
substratesweretoxictoMtb.Geneswereamplifiedwithprimersthat
encoded a His6 epitope at the 39 termini.
All primers were from Invitrogen. All plasmids were sequenced
by GENEWIZ (South Plainfield, NJ) to confirm the veracity of the
cloned sequences. Transformation was carried out using standard
techniques for E. coli [50]. Wild type, pafA and mpa mutant strains
of Mtb were transformed with test plasmids using electroporation
[51]. Mtb transformants arose after 2–3 weeks and three colonies
from each transformation were picked into 200 ml 7H9 broth with
antibiotics in 96 well plates. After one week at 37uC, these starter
cultures were inoculated into 5 ml 7H9 in vented 25 cm
2 flasks
(Corning), in duplicate, for further growth. After another week
cultures were frozen or used for immunoblot analysis.
Purification of the RCC Pupylated Substrates
0.5 l WT Mtb containing pMN-His6-Strep-Pup was grown to an
OD580 of ,1.0. Bacteria were collected by centrifugation,
resuspended in 14 ml of denaturing lysis buffer B (The
QiaExpressionist manual, Qiagen) and 1 ml aliquots of cells were
transferred to bead beating tubes each with 250 ml of zirconia
silica beads (BioSpec Products). Cells were lysed by bead beating
in a BioSpec Mini Bead Beater. Samples were clarified by
centrifugation and were then passed through a 0.2 m filter. The
lysate was incubated with 1.5 ml of Ni-NTA agarose (Qiagen) for
2 h at 4uC with agitation. The agarose was collected in a
polypropylene column and washed with denaturing wash buffer.
The matrix was then washed with 1 column volume plus 10 ml of
native wash buffer. Proteins were eluted with 3.5 ml native elution
buffer. The eluate was incubated with 1 ml of Strep-Tactin
Superflow (Qiagen) for 2 h at 4uC with agitation. The column was
washed three times with 5 ml of Strep wash buffer (50 mM
NaH2PO4/300 mM NaCl, pH 8.0) and proteins were eluted in six
500 ml fractions with Strep elution buffer (50 mM NaH2PO4/
300 mM NaCl/2.5 mM desthiobiotin, pH 8.0). 40 ml of elution
two was visualized on a 12% SDS-PAGE gel stained with Biosafe
Coomassie Blue (Bio-Rad). The entire lane was excised for tandem
MS/MS analysis.
Proteomic Analysis
For identification of proteins pulled down by TAP we used in-
gel proteolysis and LC-MS/MS analysis. The gel lane was divided
into six bands, each of which was cut into ,1 mm cubes and
transferred into 1.5 ml Eppendorf tubes. The procedure for in-gel
digestion was as described previously [52]. Briefly, the proteins
were digested overnight with trypsin at 37uCi n5 0 m M
ammonium bicarbonate. Peptides were extracted with 50%
acetonitrile, 5% formic acid, dried by vacuum centrifugation
and desalted using handmade StageTips containing C18 resin
[53]. Peptides were eluted with 50% acetonitrile, 5% formic acid
into glass inserts, and dried in a Speed-Vac.
The samples were analyzed on an LTQ Orbitrap XL hybrid
mass spectrometer (ThermoFisher) coupled to an Agilent 1100
series binary pump. Dried peptides were reconstituted in 8 ml5 %
acetonitrile, 5% formic acid of which 4 ml was loaded onto a hand-
pulled fused silica microcapillary (125 mm615 cm, packed with
Magic C18AQ, Michrom Bioresources) using a Famos autosam-
pler (LC Packings). Loaded peptides were separated across a 45 m
linear gradient of 10–37% solvent B (0.125% formic acid,
99.875% acetonitrile). Solvent A comprised 0.125% formic acid,
3% acetonitrile. Data were collected in a data-dependent mode
using the TOP10 strategy where one full high resolution MS scan
was acquired in the orbitrap followed by 10 MS/MS scans in the
linear ion trap from the top 10 most intense ions.
RAW files were converted to mzXML files using the pro-
gram ReAdW (http://sashimi.sourceforge.net/software_glossolalia.
html). MS/MS spectra were searched using the SEQUEST
search algorithm (version 27, revision 12) against an Mtb protein
database [24] using a mass tolerance of 50 ppm and a static
modification of 57.02146 Da (carboxyamidomethylation). The
search parameters for post-translational modifications comprised
dynamic modifications of 243.085522 Da on Lys (GGE) and
15.99491 Da on methionine (oxidation). Partial Trypsin was
specified with a maximum of two missed cleavages.
Protein hits were filtered at the peptide level to contain less than
0.22% false positives, estimated by the number of decoy hits using
in-house software and filtering based on dCn, XCorr, ppm, charge
state and peptides per protein. The protein false positive rate was
estimated to be 1.47%.
PhoH2 was identified by the Columbia Proteomics Core Facility
from spots found in 2D gels prepared by kendricklabs.com [20].
Protein Purification and Immunoblot Analysis
FabD-His6 and Ino1-His6 were purified under native condi-
tions; PhoH2-His6 was purified under denaturing conditions as
described elsewhere (The QiaExpressionist). PhoH2-His6 was
excised from a 10% SDS-PAGE gel. Antibodies to PhoH2 and
FabD were made by Sigma-Genosys; antibodies to Ino1 were
made by Covance. All rabbit antibodies were diluted in 1% skim
milk in TBST (25 mM Tris-HCl, pH 7.4/125 mM NaCl/0.05%
Tween 20). Secondary antibodies (GE-Healthcare) were diluted in
1% milk/TBST. To examine epitope tagged protein levels each
strain was grown under standard conditions until stationary phase
(optical density at A580 between 1–2; all samples were OD
matched). All cultures were processed exactly as described
elsewhere [38]. For immunoblot analysis, cell lysates were
separated by 10 or 12% SDS-PAGE, transferred to nitrocellulose
membranes and blocked in 3% bovine serum albumin/TBST and
incubated with monoclonal Penta-His (His5) antibodies (Qiagen)
or secondary antibodies (GE-Healthcare) in 1% milk/TBST.
To test is specific proteins were pupylated in mycobacteria, the
gene encoding the protein of interest was expressed from pSYMP
in M. smegmatis or Mtb. M. smegmatis was grown in 250 ml 7H9 and
processed as described in the QiaExpressionist manual for
purification under denaturing conditions. For Mtb, equivalent cell
numbers based on A580 readings (typically 17 optical density units)
were collected by centrifugation, washed with PBS/0.05% Tween-
80, and resuspended in 3 ml native lysis buffer (QiaExpressionist).
Bacteria were lysed by bead beating and unbroken cells were
removed by centrifugation. The supernatants were then filtered
through a 0.22 m nylon filter and incubated with 30 ml NiNTA
agarose for 2 h at 4uC on a rotator. The agarose was washed four
times with native wash buffer then eluted in 60 ml native
elution buffer. 20 ml 4 5 protein sample buffer was added to
eluates and samples were analyzed by immunoblotting with
antibodies to His5.
Supporting Information
Figure S1 Steady state levels of many RCC pupylome proteins
do not differ between wild type, pafA and mpa mutants.
Immunoblots of equivalent cell numbers from cultures grown to
an optical density (ODA580)=1.5 were analyzed. All blots were
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antibodies to DlaT, the loading control (lower panel for each blot).
Found at: doi:10.1371/journal.pone.0008589.s001 (1.44 MB
PDF)
Table S1 Peptide profile of the pupylome.
Found at: doi:10.1371/journal.pone.0008589.s002 (1.33 MB
XLS)
Table S2 Mtb peptides with pupylation sites.
Found at: doi:10.1371/journal.pone.0008589.s003 (0.07 MB
DOC)
Table S3 Bacterial strains, plasmids and primers used in this
work.
Found at: doi:10.1371/journal.pone.0008589.s004 (0.05 MB
DOC)
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